The Safety and Efficacy of High-Dose (HD) Acyclovir (ACV) in Neonatal Herpes Simplex Virus (HSV) Infections

MLA

Pamela S. Diaz, et al. “The Safety and Efficacy of High-Dose (HD) Acyclovir (ACV) in Neonatal Herpes Simplex Virus (HSV) Infections.” Pediatric Research, vol. 45, Apr. 1999, p. 165A. EBSCOhost, https://doi.org/10.1203/00006450-199904020-00980.

APA

Pamela S. Diaz, Teresa Murguı́a de Sierra, M Shelton, D W Kimberlin, F D Lakeman, Richard F. Jacobs, Kathleen Gutierrez, Lawrence Corey, John S. Bradley, L B Weiner, R J Whitley, Ann M. Arvin, S J Soong, W C Gruber, Mobeen H. Rathore, C Y Lin, M Kumar, John W Sleasman, & D A Powell. (1999). The Safety and Efficacy of High-Dose (HD) Acyclovir (ACV) in Neonatal Herpes Simplex Virus (HSV) Infections. Pediatric Research, 45, 165A. https://doi.org/10.1203/00006450-199904020-00980

Chicago

Pamela S. Diaz, Teresa Murguı́a de Sierra, M Shelton, D W Kimberlin, F D Lakeman, Richard F. Jacobs, Kathleen Gutierrez, et al. 1999. “The Safety and Efficacy of High-Dose (HD) Acyclovir (ACV) in Neonatal Herpes Simplex Virus (HSV) Infections.” Pediatric Research 45 (April): 165A. doi:10.1203/00006450-199904020-00980.